5. Summary of test accuracy at study level for conversion to Alzheimer’s disease dementia.
Studies included in meta‐analysis | ||||
Study ID | Participants (n) | Sensitivity (%) | Specificity (%) | % of MCI with ¹⁸F‐FDG PET positivity |
Anchisi 2005 | 48 | 93 | 82 | 40 |
Arnáiz 2001 | 20 | 67 | 82 | 40 |
Berent 1999 | 20 | 70 | 70 | 50 |
Chételat 2003 (temporo‐parietal brain region) |
17 | 100 | 100 | 41 |
Clerici 2009 | 26 | 92 | 15 | 88 |
Drzezga 2005 | 30 | 92 | 89 | 43 |
Fellgiebel 2007 | 16 | 100 | 75 | 44 |
Galluzzi 2010 | 38 | 79 | 29 | 74 |
Herholz 2011 (ADNI study) | 94 | 57 | 67 | 40 |
Mosconi 2004 | 37 | 38 | 97 | 10.5 |
Nobili 2008 | 33 | 82 | 91 | 33 |
Ossenkoppele 2012a | 12 | 75 | 88 | 33 |
Ossenkoppele 2012b | 12 | 83 | 100 | 42 |
Pardo 2010(Reader 1) | 18 | 25 | 60 | 32 |
Studies included only in descriptive analysis | ||||
Chételat 2003 (posterior cingulate brain region) |
17 | 100 | 90 | 47 |
Landau 2010 (ADNI study) | 85 | 75 | 47 | 60 |
Pardo 2010 (Reader 2) | 17 | 33 | 30 | 53 |
Schmand 2012 (ADNI study) | 98 | 24 | 82 | 20 |
ADNI: Alzheimer's Disease neuroimaging initiative